PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

How Clinicians Want Deprescribing Written Into Practice Guidelines

deprescribingclinical practice guidelinesolder adultspolypharmacypotentially inappropriate medicationsBeers CriteriaGLAFIGRADEqualitative researchimplementation sciencegeriatrics Geriatrics

Background Information

Enhancing deprescribing guidelines could improve care for older adults.

Deprescribing in older adults requires careful consideration, yet is often underrepresented in clinical guidelines. Improving this can enhance guideline effectiveness. Three themes emerged: need for higher content quality, clarity versus comprehensiveness balance, and optimal placement of recommendations. The study highlights the complexity of deprescribing compared to prescribing, urging more detailed and actionable recommendations in guidelines. Enhancing deprescribing recommendations can improve guideline implementation in older adults.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Langford AV, Liau SJ, Loh S, Farrell B, Thompson W, Pollock D, Moriarty F, Gnjidic D, Ailabouni NJ, Reeve E

Citation: Langford AV, Liau SJ, Loh S, et al. Designing Implementable Deprescribing Recommendations: A Qualitative Study of Healthcare Professional Perspectives. Journal of general internal medicine. 2026. doi:10.1007/s11606-026-10679-x

Article Links: PubMed · Journal / DOI

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.